DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Narayana Hrudayalaya Ltd. — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 35 min ago·18 Aug 2026, 10:28 am

Narayana Hrudayalaya

Narayana Hrudayalaya Ltd. has announced its plans to hold an investor meet and conference call on August 20, 2026. This event is scheduled to allow the company to interact directly with analysts and institutional investors, providing a platform to discuss its future strategies and performance.

For investors, such meetings are crucial as they offer a transparent look into the company's roadmap. By listening to management's commentary, investors can better understand the operational health and growth prospects of the healthcare giant, helping them make more informed decisions.

What to watch next is the specific agenda and key takeaways from the meeting. Investors should pay close attention to management's guidance on expansion plans, financial targets, and any updates on their core medical services to gauge the company's future trajectory.